Refresh
X
Gainers
Losers
Sectors
Indices
Forex
Mutual Funds
Home
Indices
Sectors
Mutual Funds
Gainers
Losers
Forex
Investment Tool
All Pages
AstraZeneca Pharma India Ltd.
BSE
Price on BSE
15 May,15:24 LIVE
8,491.85
+141.75
(+1.70%)
© 2026 Rediff.com
Volume :
146.00
Prev Close :
8,350.10
Day's H/L (Rs.) :
8,520.85 - 8,318.55
52wk H/L (Rs.) :
10,653.05 - 7,630.00
Mkt Cap (Rs. Cr) :
21,229.63
NSE
Price on NSE
15 May,15:49 LIVE
8,468.50
+116.50
(+1.39%)
© 2026 Rediff.com
Volume :
3,063.00
Prev Close :
8,352.00
Day's H/L (Rs.) :
8,499.00 - 8,316.50
52wk H/L (Rs.) :
10,691.00 - 7,551.50
Mkt Cap (Rs. Cr) :
0.00
Report Card - AstraZeneca Pharma India Ltd.
PE Ratios
183.35
EPS (Rs.)
46.30
Sales (Rs. Cr)
611.57
Face Value (Rs.)
2
Net Profit Margin(%)
6.74
Last Bonus
1:1
Last Dividend(%)
1600
Return on Average Equity
15.02
News for AstraZeneca Pharma India Ltd.
Aurobindo Pharma Gets USFDA Nod for Dapagliflozin
Aurobindo Pharma receives USFDA approval for generic dapagliflozin tablets (5mg & 10mg) to control blood sugar in type 2 diabetes.
Apr 07, 2026 19:37
Alembic Pharma Gets USFDA Nod for Dapagliflozin
Alembic Pharmaceuticals receives USFDA approval for generic dapagliflozin tablets (5mg & 10mg) to control blood sugar in type-2 diabetes.
Apr 07, 2026 12:51
AstraZeneca Imfinzi Approved in India for Endometrial Cancer
AstraZeneca Pharma India gets approval to market Imfinzi (Durvalumab) for advanced endometrial cancer treatment in India.
Feb 10, 2026 14:05
AstraZeneca Durvalumab Approved for Gastric Cancer
CDSCO approves AstraZeneca's Durvalumab with chemotherapy for gastric/gastroesophageal junction cancer treatment in India.
Feb 04, 2026 14:19
Starmer Secures UK-China Export & Investment Deals
PM Starmer concludes China visit with multi-billion pound export and investment deals, boosting UK-China relations and trade.
Jan 31, 2026 18:27
More News for AstraZeneca Pharma India Ltd. »
News for Pharmaceuticals and health care
Muthoot Fincorp IPO: Rs 4,000 Cr Planned
Muthoot Fincorp announces Rs 4,000 cr IPO after doubling FY26 net profit. Stock split & NCD issuance also approved. Details here.
May 16, 2026 22:35
Vodafone Idea Posts Profit on AGR Relief
Vodafone Idea reports Rs 51,970 cr profit in Q4 FY26, its first in six years, due to reduced statutory liabilities (AGR).
May 16, 2026 22:27
Vodafone Idea to Raise ₹4,730 Cr from Aditya Birla Group
Vodafone Idea plans to raise ₹4,730 crore from Aditya Birla Group via warrants. Capital infusion after AGR liability reduction.
May 16, 2026 22:12
Captain Polyplast Starts Production in Ahmedabad
Captain Polyplast begins production at its new Ahmedabad facility, boosting micro-irrigation systems capacity and in-house component manufacturing.
May 16, 2026 21:55
Delhivery Q4 Profit Dips, Income Rises 26%
Delhivery reports Q4 profit of Rs 72.39 crore, a slight dip from last year, but income increases by 26%. FY26 consolidated PAT declines marginally.
May 16, 2026 21:53
More News »
Top News
India, Netherlands Elevate Ties to Strategic Partnership
India and Netherlands elevate relationship to strategic partnership. Modi and Jetten discuss trade, investment, and cooperation.
May 17, 2026 01:07
India, Netherlands Strategic Partnership: Modi-Jetten Talks
India and Netherlands elevate ties to a strategic partnership after talks between PM Modi and Dutch PM Rob Jetten. Key areas of cooperation highlighted.
May 17, 2026 00:59
Modi Invites Dutch Firms to Innovate & Manufacture in India
PM Modi invites Dutch companies to design, innovate, and manufacture in India, highlighting opportunities in infrastructure, energy, and connectivity.
May 16, 2026 22:43
Muthoot Fincorp IPO: Rs 4,000 Cr Planned
Muthoot Fincorp announces Rs 4,000 cr IPO after doubling FY26 net profit. Stock split & NCD issuance also approved. Details here.
May 16, 2026 22:35
Vodafone Idea Posts Profit on AGR Relief
Vodafone Idea reports Rs 51,970 cr profit in Q4 FY26, its first in six years, due to reduced statutory liabilities (AGR).
May 16, 2026 22:27
More Top News »
Sectoral Indices
Market Indicators
Listed Companies
Gainers
Losers
Mutual Funds
Portfolio
Watchlist